| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/01/2005 | US6861071 Highly absorptive solid preparation |
| 03/01/2005 | CA2288334C Method of manufacturing sertindole |
| 03/01/2005 | CA2138287C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/24/2005 | WO2005016918A2 Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 02/24/2005 | WO2005016917A1 Process for preparing isomerically pure prodrugs of proton pump inhibitors |
| 02/24/2005 | WO2005016916A2 Substituted quinolines serving as antimicrobial agents |
| 02/24/2005 | WO2005016915A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators |
| 02/24/2005 | WO2005016914A1 Chemical compounds |
| 02/24/2005 | WO2005016913A1 Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders |
| 02/24/2005 | WO2005016912A1 An efficient microbial preparation of capravirine metabolites m4 and m5 |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2005016910A1 Pyridyltetrahydropyridines, pyridylpiperidines, and process for the production of both |
| 02/24/2005 | WO2005016897A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 02/24/2005 | WO2005016896A1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 02/24/2005 | WO2005016894A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/24/2005 | WO2005016892A1 Gabanergic modulators |
| 02/24/2005 | WO2005016890A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 02/24/2005 | WO2005016885A2 COMPOUNDS WITH COMBINED CALCIUM CHANNEL BLOCKER AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITIES FOR TREATMENT OF HEART DISEASE |
| 02/24/2005 | WO2005016883A2 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
| 02/24/2005 | WO2005016879A2 Cyclic pyrazinoylguanidine sodium channel blockers |
| 02/24/2005 | WO2005016876A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016346A1 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 02/24/2005 | WO2005016344A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | WO2005016326A2 Analogs of thalidomide as potential angiogenesis inhibitors |
| 02/24/2005 | WO2005016000A1 Derivatives of cyclic quinone and uses thereof |
| 02/24/2005 | WO2005005393A3 Cck-1 receptor modulators |
| 02/24/2005 | WO2004093789A3 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 02/24/2005 | WO2004087056A3 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ |
| 02/24/2005 | WO2004046103A3 Arylpyridine compounds |
| 02/24/2005 | WO2004031175A3 N-substituted-2-oxodihydropyridine derivatives as npy antagonists |
| 02/24/2005 | US20050043552 Process for the synthesis of amine ethers from secondary amino oxides |
| 02/24/2005 | US20050043543 Benzotriazole/HALS molecular combinations and compositions stabilized therewith |
| 02/24/2005 | US20050043535 4-(Piperidyl-and pyrrolidyl-alkyl-ureido)-quinolines as urotensin II receptor antagonists |
| 02/24/2005 | US20050043390 Viricides against herpes virus |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043381 Aminopyrazole compounds |
| 02/24/2005 | US20050043379 Leukotriene hydrolase inhibitors; antiinflammatory agents; antihistamines; chronic onstructive pulmonary disorders; atherosclerosis; multiple sclerosis; inflammatory bowel disorders; antiarthritic agents ;psoriasis |
| 02/24/2005 | US20050043378 LTA4H modulators |
| 02/24/2005 | US20050043368 Osteoporosis therapy; bone disorders |
| 02/24/2005 | US20050043366 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 02/24/2005 | US20050043364 Novel pyrrole-based HMG-CoA reductase inhibitors |
| 02/24/2005 | US20050043363 Efficient microbial preparation of capravirine metabolites M4 and M5 |
| 02/24/2005 | US20050043357 Mitotic kinesin inhibitors |
| 02/24/2005 | US20050043354 Substance P antagonist |
| 02/24/2005 | US20050043352 human YAK family of serine/threonine protein kinases (hyak); use treating diseases of the hematopoietic systems, including anemias, polycythemia, myelodysplastic syndrome, myelosuppression, cytopenia, male contraceptives; 2-(3-Chloro-phenylamino)-7-methoxy-quinoline-3-carboxylic acid for example |
| 02/24/2005 | US20050043348 Phenyl-substituted imidazopyridines |
| 02/24/2005 | US20050043338 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/24/2005 | US20050043337 Selective beta3 adrenergic agonists |
| 02/24/2005 | US20050043336 Quinazoline derivatives as antitumor agents |
| 02/24/2005 | US20050043335 Heterocyclic derivatives of glycinamide and their medical use |
| 02/24/2005 | US20050043334 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer |
| 02/24/2005 | US20050043333 Quinazolinone derivative |
| 02/24/2005 | US20050043331 Substituted 3-(2,5-disubstituted)pyridyl-4-aryl pyrroles for treating inflammatory diseases |
| 02/24/2005 | US20050043330 Antiinflammation agents |
| 02/24/2005 | US20050043316 Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 02/24/2005 | US20050043315 Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them |
| 02/24/2005 | US20050043314 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/24/2005 | US20050043313 1-(phenylaminocarbonylmethyl)-3-alkylamino-5,6-disubstituted-2-pyazinones; serine protease inhibitors; anticoagulants; coronary artery and cerebrovascular diseases |
| 02/24/2005 | US20050043310 Such as (R)-4-bromo-N-[1-(2,4-dichlorophenyl)-ethyl]-2-(quinoxaline-5-quinoxaline-sulfonylamino)-benzamide via sulfonylation; cholecystokinin receptor modulators |
| 02/24/2005 | US20050043307 Novel heterocycle as agonist or antagonist for nervous systems which can contain double or triple bonds with nitrogen, oxygen or sulfur with carbon or azo groups and or salts and as modulators or receptors with carriers |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043302 New indole derivatives as factor Xa inhibitors |
| 02/24/2005 | US20050043301 Substituted heterocyclic compounds and methods of use |
| 02/24/2005 | US20050043300 Piperazine derivatives |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050043292 eg S)-[5-amino-6-oxo-6-(3,3,4,4-tetrafluoro-pyrrolidin-1-yl)-hexyl-carbamic acid benzylester; Type 2 diabetes, metabolic syndrome (syndrome X or insulin resistance syndrome), hyperglycemia, impaired glucose tolerance, glucosuria, metabolic acidosis, arthritis, cataracts, diabetic neuropathy |
| 02/24/2005 | US20050043291 Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 02/24/2005 | US20050043290 for treating neurodegenerative disease such as Alzheimer's disease |
| 02/24/2005 | US20050043277 Production of imidazole derivatives and novel intermediates of the derivatives |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | US20050042614 Point mutations; dipeptidyl-peptidase inhibitors; kits |
| 02/24/2005 | US20050042304 Novel substituted benzimidazole dosage forms and method of using same |
| 02/24/2005 | DE10331500A1 Neue Acridin-Derivate und deren Verwendung als Arzneimittel New acridine derivatives and their use as medicaments |
| 02/24/2005 | DE102004010545A1 Pyrazoline Pyrazolines |
| 02/24/2005 | CA2743534A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2535406A1 Gabanergic modulators |
| 02/24/2005 | CA2535020A1 Substituted quinolines serving as antimicrobial agents |
| 02/24/2005 | CA2534950A1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | CA2534887A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 02/24/2005 | CA2534866A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | CA2532104A1 Process for preparing isomerically pure prodrugs of proton pump inhibitors |
| 02/24/2005 | CA2518774A1 Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 02/23/2005 | EP1508569A2 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
| 02/23/2005 | EP1507826A2 Amelioration of the development of cataracts and other opthalmic diseases |
| 02/23/2005 | EP1507775A1 Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 02/23/2005 | EP1507774A1 Processes for preparation of polymorphic forms of desloratadine |
| 02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
| 02/23/2005 | EP1507768A1 Aryl-alkyne compounds as herbicides |
| 02/23/2005 | EP1507767A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors |
| 02/23/2005 | EP1507764A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions |
| 02/23/2005 | EP1507761A1 Pyridine carboxamide derivatives and their use as pesticides |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1507759A1 Cyanoguanidine produgs |
| 02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| 02/23/2005 | EP1507534A2 Compounds, compositions and methods |
| 02/23/2005 | EP1507531A2 Stable pharmaceutical compositions of desloratadine |
| 02/23/2005 | EP1507529A1 Combination of organic compounds |